Humalog, a rapidly absorbed analog of human insulin, determined with Coat-A-Count insulin radioimmunoassay.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Clinical Chemistry

• Publication date

  1995-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/CLINCHEM/41.12.1777PMID 7497622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I.

  1994cited by this paper
• [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

  1994cited by this paper
• Altering the association properties of insulin by amino acid replacement.

  1992cited by this paper
• Guidelines for immunoassay data processing.

  1985cited by this paper
• Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

  1978cited by this paper
• Statistical estimation of the minimal detectable concentration ("sensitivity") for radioligand assays.

  1978cited by this paper

• Attempted Murder of a Young Child Followed by an Attempted Suicide of the Mother by Injection of Insulin Aspart: Identification of Quantification of Insulin by LC-HRMS and UPLC-MS/MS in Blood of the Two Cases.

  2021cites this paper
• Development and validation of an electrochemiluminescent ELISA for quantitation of oral insulin tregopil in diabetes mellitus serum.

  2017cites this paper
• Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods.

  2011cites this paper
• Application of size-exclusion chromatography in the investigation of the in vitro stability of proinsulin and its cleaved metabolites in human serum and plasma.

  2009cites this paper
• Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays.

  2004cites this paper
• Intramuscular injection of insulin lispro or soluble human insulin: pharmacokinetics and glucodynamics in Type 2 diabetes

  2001cites this paper
• An immunoadsorption strategy to produce specific antisera against analogs of human proteins: development of sensitive and specific radioimmunoassays for two analogs of human leptin.

  2000cites this paper
• A time-resolved fluorescence immunoassay for insulin in rodent plasma.

  1999cites this paper
• Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

  1999cites this paper
• Sensitive RIA for the specific determination of insulin lispro.

  1999cites this paper
• Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.

  1999cites this paper
• Insulin Lispro: In‐vivo Potency Determination by Intravenous Administration in Conscious Rabbits

  1999cites this paper
• Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.

  1997cites this paper
• Meal Composition is a Determinant of Lispro-Induced Hypoglycemia in IDDM

  1997cites this paper
• Nighttime Insulin Kinetics and Glycemic Control in Type 1 Diabetes Patients Following Administration of an Intermediate-Acting Lispro Preparation

  1997cites this paper
• Validity of Coat-A-Count insulin RIA kit for quantifying total and free humalog.

  1996cites this paper
• Cross-Reactivity of Three Recombinant Insulin Analogs with Five Commercial Insulin Immunoassays

  year unknowncites this paper